13F Filings History of Corriente Advisors, LLC
- Form 13F summary
-
- Corriente Advisors, LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- Corriente Advisors, LLC reported 2 equity holdings with a total reported market value of $3,449,812 for Q3 2023.
- Manager signature
- Matthew H. Gilman - CFO / CCO
- Manager location
- Fort Worth, TX
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Corriente Advisors, LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q3 2023
Latest value
$3,449,812
Quarter delta
$0
Accepted
14 Nov 2023, 15:38
Rows shown
1-17 of 17
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | $0 | -$3,449,812 | -$3,449,812 | 13F-HR | 13 Feb 2024, 19:29 | |
| Q3 2023 | 2 | $3,449,812 | +$3,449,812 | -$10,872,000 | -$7,422,188 | NXE, RGTIW | 13F-HR | 14 Nov 2023, 15:38 |
| Q2 2023 | 2 | $10,872,000 | +$10,872,000 | -$976,400 | +$9,895,600 | AUR, JOBY | 13F-HR | 08 Aug 2023, 18:59 |
| Q1 2023 | 2 | $976,400 | +$976,400 | $0 | +$976,400 | AI, BBAI | 13F-HR | 10 May 2023, 16:04 |
| Q4 2022 | 0 | $0 | $0 | $0 | $0 | 13F-HR | 15 Feb 2023, 14:53 | |
| Q3 2022 | 0 | $0 | $0 | $0 | $0 | 13F-HR | 15 Nov 2022, 14:02 | |
| Q2 2022 | 0 | $0 | $0 | $0 | $0 | 13F-HR | 15 Aug 2022, 18:49 | |
| Q1 2022 | 1 | $1,622,000 | +$1,622,000 | -$8,331,000 | -$6,709,000 | NBR | 13F-HR | 16 May 2022, 16:20 |
| Q4 2021 | 2 | $8,331,000 | +$8,331,000 | -$51,796,000 | -$43,465,000 | CPG, APRN | 13F-HR | 15 Feb 2022, 15:06 |
| Q3 2021 | 8 | $51,796,000 | +$30,981,000 | -$166,684,219 | -$135,703,219 | CUE, SWN, TFFP, LTRN, VET | 13F-HR | 15 Nov 2021, 11:23 |
| Q2 2021 | 15 | $185,402,000 | +$54,446,000 | -$139,400,365 | -$84,954,365 | MAXR, CUE, REPL, COIN, RETA | 13F-HR | 16 Aug 2021, 09:08 |
| Q1 2021 | 10 | $271,579,000 | +$76,642,632 | -$193,929,563 | -$117,286,931 | MAXR, REPL, CUE, CRDF, TDY | 13F-HR | 18 May 2021, 09:08 |
| Q4 2020 | 19 | $420,091,000 | +$217,731,488 | -$31,541,400 | +$186,190,088 | MAXR, RETA, REPL, CRDF, CCJ | 13F-HR | 16 Feb 2021, 16:26 |
| Q3 2020 | 16 | $197,205,000 | +$94,410,675 | -$49,220,000 | +$45,190,675 | MAXR, RETA, CUE, APTOSE BIOSCIENCES INC, TFFP | 13F-HR | 03 Nov 2020, 14:50 |
| Q2 2020 | 16 | $154,336,000 | +$64,326,764 | -$29,258,272 | +$35,068,492 | MAXR, RETA, SONO, APTOSE BIOSCIENCES INC, CUE | 13F-HR | 13 Aug 2020, 17:37 |
| Q1 2020 | 11 | $92,638,000 | +$38,953,710 | -$104,798,599 | -$65,844,889 | RETA, MAXR, APTOSE BIOSCIENCES INC, CUE, GBTC | 13F-HR | 18 May 2020, 10:33 |
| Q4 2019 | 16 | $183,240,000 | $0 | $0 | $0 | MAXR, RETA, SPCE, QURE, TPTX | 13F-HR | 13 Feb 2020, 18:01 |